Alerts

We have made a Serious Scarcity Substitution Instrument (SSSI) that starts on 22 December 2025 and ends on 28 April 2026. The SSSI allows a pharmacist to dispense an equivalent quantity of clonidine 100 mcg tablets, if appropriate, without a new prescription

Pharmaceutical companies Novo Nordisk and Eli Lilly are discontinuing some of their insulin products.

The company which has supplied the CellAED devices, RRR Manufacturing Pty Ltd, has gone into liquidation. The liquidators for RRR Manufacturing, are conducting a Critical Recall for all lots of the CellAED device.

Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.

Key Sun Laboratories Pty Ltd is recalling one batch of Key Sun Kids Travel Sickness Homeopathic Product, due to the risk of a small metal wire being present in the lozenge.

Pharmacists can substitute 10 mg simvastatin tablets during the shortage of the 5 mg tablets.

Vitality Brands Worldwide Pty Ltd is recalling three batches of Cancer Council Sunscreen Clear Zinc Kids SPF50+ 110g due to the potential for the product to become separated.

Pharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.

Bondi Sands Pty Ltd is recalling five batches of sunscreen due to the potential for the lotions to become separated.

Product correction: Ypsomed Australia is reminding users to ensure they use a compatible smart device and operating system (OS) when using the Mylife CamAPS FX app.

We have extended the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Labetalol) Instrument 2025 (SSSI) to 31 December 2025.

Phytologic Holdings Pty Ltd is recalling one batch of Henry Blooms Infant Liquid D3 & K2 with Probiotic due to a dosing syringe error.

Consumers are advised that several sunscreen products are being recalled by sponsors. This follows preliminary testing evidence indicating that the SPF levels of their products may be lower than what is claimed on their labels.

Stryker is conducting a Critical Product Correction of Pad-Paks used with the HeartSine samaritan Public Access Defibrillator (PAD), with an expiry date range between 17 April 2025 to 01 August 2029.

Product correction and Product alert. This update includes new information regarding the software correction, actions for healthcare professionals and inclusion of the single chamber (SR) pacemaker.

Pharmacists can dispense 200 mg tablets during the shortage.

Grace & Fire Pty Ltd (trading as Ultra Violette) is recalling all batches of Ultra Violette Lean Screen SPF 50+ due to inconsistency in the SPF level of the product.

Star Combo Australia Pty Ltd is recalling multiple batches of four Living Healthy High Strength Gummies products due to non-compliant labelling.

Product Alert: Australasian Medical & Scientific Ltd (AMSL), the sponsor of the t:slim X2 insulin pump, has identified that certain versions of the device have a wiring problem with the speaker.

Invacare Australia is updating the Instructions for Use (IFU) of the Birdie Lifter and Compact Lifter. Users need to be aware of the correct position for the carabiner and the correct attachment of the hanger bar.

Homart Pharmaceuticals Pty Ltd is recalling specific batches of its product, SpringLeaf Fat Clear, due to two identified compliance problems.

Concerta modified-release tablets will remain in shortage at various times until the end of 2026

Well Herb is recalling batch numbers: DB0014M & DB0015M with expiry Date 11/12/2027 supplied in Australia of Xinyi Biyan Pills due to the medicine having unacceptable amounts of lead above the permitted daily dose.

Due to ongoing problems with their A30 and A40 series BiPAP devices, Philips is now contacting those affected to organise replacement devices or discuss alternative options.

All strengths of the Mounjaro vial presentation are discontinued but the Mounjaro KwikPen is available in the same strengths.